企業プロフィール · Healthcare

West Pharmaceutical Services Inc

WST · 米国株
業種
Packaging
取引所
米国株
国 / 地域
USA
上場日
1978年1月13日
従業員数
10,800
公式サイト
www.westpharma.com
現在値
$327.95
リアルタイム · 2026年6月18日
妥当買付価格
≤ $240
安全マージンの起点
ベイリー成長スコア
44/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $327.95 リアルタイム · 楽観的な本源的価値レンジ内 · 多くの期待を織り込み済み

総合バリュエーションレンジ · 保守的 $135–$165 / 妥当 $190–$240 / 楽観的 $280–$330。$327.95 時点で 楽観的な本源的価値レンジ内 · 多くの期待を織り込み済み。

レポート公開時 $321.8(2026年5月29日)

この銘柄のレポートはお使いの言語でまだありません。

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

時価総額$228.61億
売上高(TTM)$32.21億
EBITDA$8.7億
純利益率16.85%
ROE19.13%
PER (TTM)43.26
予想PER38.31
PEG3.17
EPS$7.48
配当利回り0.26%
52週レンジ$206.12 – $336.82
アナリスト目標株価$358.79
アナリスト評価4.7 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。